Eric Esser is President and Chief Executive Officer of Telesis Bio, having first joined the company as Chief Operating Officer in May 2022. He stepped into the CEO role in April 2024, bringing with him over 25 years of leadership experience across sales, marketing, operations, and product development. Esser’s career spans a broad range of global leadership roles, with a particular focus on scaling early-stage, high-growth life science companies. His cross-functional expertise and deep industry knowledge continue to shape the future of synthetic biology and innovation at Telesis Bio.
Breakthroughs in synthetic biology could help accelerate advances in applications from novel infectious disease vaccines, precision immunotherapy for cancer and antibody therapeutics to creation of engineered meat substitutes and sustainable cellular agricultural products.